VERALOX THERAPEUTICS

LIVE

Serial Number

97419155

Owner

Veralox Therapeutics Inc.

Attorney

Susan Piascik Christoff

Filing Date

May 19, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

VERALOX THERAPEUTICS Trademark

Serial Number: 97419155 • Registration: 8005322

VERALOX THERAPEUTICS is a trademark filed by Veralox Therapeutics Inc. on May 19, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Veralox Therapeutics Inc. (6 trademarks)

Frederick, MD 21704

Entity Type: 03

Legal Representation

Attorney of Record

Susan Piascik Christoff

529 trademarks filed View all →

Correspondence Address

Susan Piascik Christoff Cooley LLP

1299 Pennsylvania Ave NW, Suite 700

Washington, DC 20004

United States

Trademark Details

Filing Date

May 19, 2022

Registration Date

October 28, 2025

Published for Opposition

April 18, 2023

Goods & Services

Pharmaceutical products, namely, chemical and small molecule preparations for use in treatment of blood disorders; pharmaceutical formulations for treatment of blood disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 28, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Oct 28, 2025 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 3, 2025 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 3, 2025 CNPR

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jun 30, 2025 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jun 30, 2025 XELR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 9, 2025 GNRN

NON-FINAL ACTION E-MAILED

Apr 9, 2025 GNRT

SU - NON-FINAL ACTION - WRITTEN

Apr 9, 2025 CNRT

STATEMENT OF USE PROCESSING COMPLETE

Feb 21, 2025 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 21, 2025 AITU

USE AMENDMENT FILED

Dec 10, 2024 IUAF

TEAS STATEMENT OF USE RECEIVED

Dec 10, 2024 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 10, 2024 EXRA

SOU EXTENSION 3 GRANTED

Dec 10, 2024 EX3G

SOU EXTENSION 3 FILED

Dec 10, 2024 EXT3

SOU TEAS EXTENSION RECEIVED

Dec 10, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 16, 2024 EXRA

SOU EXTENSION 2 GRANTED

May 15, 2024 EX2G

SOU EXTENSION 2 FILED

May 15, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

May 15, 2024 EEXT

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 12, 2024 TCCA

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Feb 12, 2024 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Feb 12, 2024 COAR

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 8, 2024 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Feb 8, 2024 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Feb 8, 2024 REAP

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 13, 2023 EXRA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Dec 12, 2023 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Dec 12, 2023 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Dec 12, 2023 REAP

SOU EXTENSION 1 GRANTED

Dec 11, 2023 EX1G

SOU EXTENSION 1 FILED

Dec 11, 2023 EXT1

SOU TEAS EXTENSION RECEIVED

Dec 11, 2023 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 13, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 18, 2023 NPUB

PUBLISHED FOR OPPOSITION

Apr 18, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 29, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 16, 2023 CNSA

EXAMINER'S AMENDMENT ENTERED

Mar 16, 2023 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 16, 2023 GNEN

EXAMINERS AMENDMENT E-MAILED

Mar 16, 2023 GNEA

EXAMINERS AMENDMENT -WRITTEN

Mar 16, 2023 CNEA

ASSIGNED TO EXAMINER

Mar 8, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 25, 2022 NWOS

NEW APPLICATION ENTERED

May 23, 2022 NWAP

Related Trademarks

More from this Owner

V VERALOX THERAPEUTICS

VERALOX THERAPEUTICS V

More in Same Class

ENFINITY